Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Patents
Unigen issued new patent on Chinese skullcap derivative to support joint health ingredient
February 14th, 2007
Unigen Pharmaceuticals, Inc., a research and development company of proprietary, biologically active plant-derived ingredients, has received notification of approval of a U.S. patent for free-b-ring flavonoids derived from Chinese skullcap in supporting its novel Univestin joint health ingredient. This patent brings to 151 the number of U.S. and international patents globally awarded or pending for Unigen. "Unigen's PhytoLogix discovery platform has yielded many proprietary bioactive natural products," said Qi Jia, PhD, lead inventor and chief science officer for Unigen Pharmaceuticals. "The previously issued patent on flavans from Acacia species...
Source: Medical Patent Law Weekly (2007-02-14)
|
